Mass Spectrometry-Based Strategies for Assessing Human Exposure Using Hemoglobin Adductomics
Chemical Research in Toxicology · 18.12.2023 · 36 (12) · 2019-2030
DOI: 10.1021/acs.chemrestox.3c00294 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemical Research in Toxicology, online erschienen am 14.11.2023. Verfasst von Andrew T Rajczewski und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, University of Minnesota, Minneapolis, Minnesota55455, United States. Hauptthemen laut MEDLINE: Dinitrochlorobenzene, Hemoglobins. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, Svenska Forskningsr?det Formas, National Cancer Institute.
Abstract (Originalsprache)
Hemoglobin (Hb) adducts are widely used in human biomonitoring due to the high abundance of hemoglobin in human blood, its reactivity toward electrophiles, and adducted protein stability for up to 120 days. In the present paper, we compared three methods of analysis of hemoglobin adducts: mass spectrometry of derivatized N-terminal Val adducts, mass spectrometry of N-terminal adducted hemoglobin peptides, and limited proteolysis mass spectrometry . Blood from human donors was incubated with a selection of contact allergens and other electrophiles, after which hemoglobin was isolated and subjected to three analysis methods. We found that the FIRE method was able to detect and reliably quantify N-terminal adducts of acrylamide, acrylic acid, glycidic acid, and 2,3-epoxypropyl phenyl ether (PGE), but it was less efficient for 2-methyleneglutaronitrile (2-MGN) and failed to detect 1-chloro-2,4-dinitrobenzene (DNCB). By contrast, bottom-up proteomics was able to determine the presence of adducts from all six electrophiles at both the N-terminus and reactive hemoglobin side chains. Limited proteolysis mass spectrometry, studied for four contact allergens (three electrophiles and a metal salt), was able to determine the presence of covalent hemoglobin adducts with one of the three electrophiles (DNCB) and coordination complexation with the nickel salt. Together, these approaches represent complementary tools in the study of the hemoglobin adductome.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry, University of Minnesota, Minneapolis, Minnesota55455, United States.
- Department of Environmental Science, Stockholm University, SE-10691Stockholm, Sweden.
- Department of Medicinal Chemistry and the Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota55455, United States.
ORCID-Profile: Andrew T Rajczewski, Lorena Ndreu, Alexander K Hurben, Timothy J Griffin, Margareta Å Törnqvist, Natalia Y Tretyakova, Isabella Karlsson
Förderung
- NCI NIH HHS
- Svenska Forskningsr?det Formas
- National Cancer Institute
- Stockholms Universitet
- University of Minnesota
- Kungliga Fysiografiska S?llskapet i Lund
Zitieren
APA
Rajczewski, A. T., Ndreu, L., Vryonidis, E., Hurben, A. K., Jamshidi, S., Griffin, T. J., Törnqvist, M. Å., Tretyakova, N. Y., & Karlsson, I. (2023). Mass Spectrometry-Based Strategies for Assessing Human Exposure Using Hemoglobin Adductomics. Chemical Research in Toxicology, 36(12), 2019-2030. https://doi.org/10.1021/acs.chemrestox.3c00294
Vancouver
Rajczewski AT, Ndreu L, Vryonidis E, Hurben AK, Jamshidi S, Griffin TJ, et al. Mass Spectrometry-Based Strategies for Assessing Human Exposure Using Hemoglobin Adductomics. Chemical Research in Toxicology. 2023;36(12):2019-2030. doi:10.1021/acs.chemrestox.3c00294
BibTeX
@article{Rajczewski2023,
author = {Rajczewski, Andrew T and Ndreu, Lorena and Vryonidis, Efstathios and Hurben, Alexander K and Jamshidi, Sara and Griffin, Timothy J and Törnqvist, Margareta Å and Tretyakova, Natalia Y and Karlsson, Isabella},
title = {Mass Spectrometry-Based Strategies for Assessing Human Exposure Using Hemoglobin Adductomics},
journal = {Chemical Research in Toxicology},
year = {2023},
volume = {36},
number = {12},
pages = {2019--2030},
doi = {10.1021/acs.chemrestox.3c00294}
}
EUVIMED